Medite Cancer Diagnostics 

Medite Cancer Diagnostics, Inc. functions as a specialized medical technology enterprise focused on the development, manufacturing, and commercialization of molecular biomarkers, sophisticated medical devices, and consumables. These products are engineered for the detection, risk assessment, and precise diagnosis of cancerous, pre-cancerous, and related conditions. The company's diverse product portfolio includes a range of essential laboratory instruments: the USE 33, an ultrasonic decalcification instrument that operates automatically under controlled temperatures; the TPC 15 Duo and Trio for tissue processing; TES 99 and TES Valida cooling units; and microtomes such as the M530, A550, M380 for tissue sectioning, alongside the M630 freezing microtome. Additionally, Medite offers automated solutions for slide preparation, including the TST44 robotic multi-staining system, the COT 20 linear staining system, and robotic coverslippers like the RCM 9000, ACS 720, and TWISTER. A notable innovation is the SoftKit device, designed for self-collection of samples, enabling a comprehensive health assessment of the entire female genital tract. Medite distributes its products through both direct sales channels and a network of distributors across significant markets, including the United States, China, Europe, and North Africa. Its primary clientele consists of histology and cytology laboratories within hospitals, research institutions, and independent diagnostic facilities. The company is based in Orlando, Florida.